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An N-acylated glucagon-like peptide 1 derivative was characterized by Fourier transform ion
cyclotron resonance mass spectrometry. Both electron capture dissociation (ECD) and sus-
tained off-resonance irradiation collisionally activated dissociation (SORI-CAD) were em-
ployed. While ECD revealed full sequence coverage, site of modification, branching point,
structure of the palmitoylated modification, SORI-CAD produced less complete and more
ambiguous information attributable to facile losses of the fatty acid group from both parent
and fragments. Thus, ECD showed a superior characterization performance over SORI-CAD in
analysis of N-acylated polypeptides. (J Am Soc Mass Spectrom 2005, 16, 548–552) © 2005
American Society for Mass SpectrometryThe non-insulin-dependent diabetes mellitusalso known as Type 2 diabetes is the mostcommon form of diabetes. Type 2 diabetes has
been considered a disease of overweight adults that
develops starting in middle life, but now an increas-
ing number of incidents are being found throughout
the whole population. Therefore, Type 2 diabetes
represents an increasing health challenge of the West-
ern civilization. So far, this type of diabetes has to
some extent been treated in obese persons through
the indirect regulation of plasma glucose concentra-
tion. After the discovery of the glucagon-like pep-
tides (GLP) [1], GLP-1 has received much attention
because of its many useful features, although the
complete physiological role in healthy humans and
animals is not yet fully identified [2]. Among func-
tions are the insulinotropic action [3], inhibition of
gastric emptying and gastric acid secretion [4], stim-
ulation of growth and proliferation of pancreatic
 -cells [5], which are all highly desirable in regulating
Type 2 diabetes. GLP-1 could therefore be of great
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doi:10.1016/j.jasms.2005.01.009value in the treatment of Type 2 diabetes and im-
paired glucose tolerance.
The full amino acid sequence of GLP-1 is 1HDEFER-
HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG37, where-
as the active hormone is the truncated 7GLP-136 amide
that has 50% homology with glucagon. Both degrada-
tion by dipeptidyl peptidase IV causing inactivity [6] and
renal clearance [7] are severe, making once daily admin-
istration impossible. These disadvantageous processes
can, however, to some extent be circumvented by fatty
acid derivatization that facilitates binding to serum albu-
min [8].
Mass spectrometry is an increasingly valuable tool
used in chemistry, biochemistry, molecular biology,
proteomics, and life sciences. The mass spectrometric
characterization of compounds relies not only on mea-
suring m/z, in which isomers are indistinguishable, but
also on unimolecular dissociation in the gas phase. The
observed ion fragment masses can then be recon-
structed into the original molecule under investigation.
Tandem mass spectrometry is thus a fast and powerful
tool for compound characterization. Unimolecular frag-
mentation in the gas phase can be performed by em-
ploying several techniques, e.g., infrared multiphoton
dissociation (IRMPD, [9]), black-body infrared radiative
dissociation (BIRD, [10]), sustained off-resonance irra-
diation collisionally activated dissociation (SORI-CAD,
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549J Am Soc Mass Spectrom 2005, 16, 548–552 ECD OF AN N-ACYLATED GLP-1 PEPTIDE[11]) and electron capture dissociation (ECD, [12]). The
latter technique has shown promising advantages for
characterizing polypeptides with labile modifications,
e.g., phosphorylation [13, 14], O-glycosylation [15], N-
glycosylation [16], -carboxylation [17], and O-acylation
[18].
In the current study, an N-acylated polypeptide from
GLP-1 [8] is characterized for the first time by electro-
spray ionization (ESI) Fourier-transform ion cyclotron
resonance (FTICR) tandem mass spectrometry with
ECD and SORI-CAD. The derivative is currently one of
the best drug candidates for treatment of Type 2 diabe-
tes via the GLP-1 receptor target.
Experimental
Sample
The -L-glutamoyl(N-hexadecanoyl)-R34-7GLP-137 poly-
peptide (MW 3751) was synthesized in-house and was
described elsewhere [8].
Mass Spectrometry
The polypeptide was dissolved in a standard electros-
pray mixture of water, methanol and acetic acid (49:
49:2, v/v) to the concentration of 105 M. A 3–5 l
aliquot was loaded into a metal-coated pulled-glass
capillary (Proxeon, Odense, Denmark). Nano-electros-
pray ionization (nESI) using a hexapole-based interface
(Analytica, Branford, MA) modified with a heated
metal capillary was performed on a 4.7 T Ultima FT
mass spectrometer from IonSpec (Irvine, CA). The elec-
trospray-produced multiply charged ions were exter-
nally accumulated in the hexapole for 0.5 s and then
transmitted to the ICR cell by RF-only quadrupolar ion
guides. Capture of ions in an open-ended cylindrical
cell with extra trapping plates was achieved by gated
trapping. For ECD, the ions of interest were isolated by
application to the excitation electrodes of a pre-pro-
grammed waveform. An indirectly heated dispenser
cathode ca. 3 mm in diameter operated at 5 V and 1.18
A was employed [19]. During ECD, the electron-emit-
ting surface was biased to 1 V for 100–200 ms.
Between 100 and 200 acquisitions were accumulated
and averaged. In Fourier transformation of the time
domain, one zero-filling without apodization was per-
formed. Mass spectra were peak-matched with respect
to the parent ion peak. Collisionally activated dissocia-
tion (CAD) was performed in comparison employing
sustained off-resonance irradiation (SORI). In-cell iso-
lated parent ions were excited by a dipolar RF burst (10
Vb-p) at a frequency 2 kHz lower than the resonance
frequency of the parent ion for 500 ms while increasing
the pressure. A pulsed valve was opened for 2 ms that
was connected to a reservoir filled with N2 gas at a
pressure of 21 torr. Twenty acquisitions were accumu-
lated and averaged.Results and Discussion
In the electrospray spectrum (not shown) of the 7GLP-137
derivative, abundant multiply charged species of 4 and
3 were observed that corresponded to the molecular
mass of 3748.95 Da. Compared to the nonderivatized
7GLP-137 peptide (3353.67 Da) this was a mass difference
of 395.28 Da. The highest and most abundant charge state
(4), reflecting the presence of four basic residues in the
sequence, was selected for electron capture dissociation. In
the ECD spectrum of the derivative (Figure 1), full se-
quence coverage was obtained except the cleavage be-
tween the first two amino acids at the N-terminal side
(97%), as c1
= (here, the c= nomenclature [20] is used to
indicate the incorporation of a hydrogen atom in the
c-fragment) was outside the recorded mass range and a
z30-fragment was not observed (neither as 2 nor as 3).
However, the mass of the c2
= ion unambiguously corre-
sponding to the mass of the amino acid pair histidine and
alanine, was therefore a positive identification of these
two amino acids, but not the order. In the derivatized
polypeptide, arginine was correctly assigned at the amino
acid position 34, which differs from the original 7GLP-137
polypeptide that had a lysine residue at that position. This
leaves the remaining derivatized polypeptide with amod-
ification of 367.27 Da. From the c=-ion sequence pattern the
difference between c19
= and c20= corresponded to the
mass of a lysine amino acid residue and the modification,
which permitted the localization of the modification to
lysine26. Likewise, the difference between the z11
· and the
z12
· ions was 495.31 Da that also matched the modified
lysine26.
The structure of the modification itself was revealed
from the regions near the charge-reduced species [M 
4H  e]3· (also known as the (M·  X) region [21]) and
[M 4H 2e]2. A loss of 255.27 Da from the [M 4H
 e]3· species indicated loss of palmitoyl amide
(255.256 Da, see Scheme 1). This loss was also seen from
the doubly-reduced species, [M  4H  2e]2. The
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Figure 1. ECD MS/MS spectrum of the quadruply charged (m/z
938) -L-glutamyol(N-hexadecanoyl) modified Arg34-7GLP-137
derivative. The inter residue cleavage sites are shown at the upper
right corner. The -L-glutamyol(N-hexadecanoyl) modification is
shown as X and X represents the complete loss of the modifica-
tion leaving the intact polypeptide. Loss of part of the modifica-
tion (palmitoyl amide) is shown as: Palm (200 scans).C16:0 fatty acyl chain was linked to the N-amine group
550 HASELMANN ET AL. J Am Soc Mass Spectrom 2005, 16, 548–552of an amino acid residue through an amide bond
(N-acyl modified). The CON bond between the palmi-
toyl and the glutamoyl residue was cleaved in ECD
analogous to an equivalent peptide backbone bond, i.e.,
hydrogen atom transfer to the proton solvating car-
bonyl oxygen upon electron capture, followed by a
radical site initiated -cleavage to form a c=-type neutral
fragment, which in this case had the same mass as
palmitoyl amide (marked in Figure 1 as Palm and seen
in Scheme 1 as the 255 Da loss. This loss corresponds to
the incorporation of a hydrogen atom). In an equivalent
study by Guan [18] of O-acylated polypeptides, a loss of
the full fatty acid chain was observed as well. The
second part of the modification that linked the palmi-
toyl moiety to the polypeptide chain was a glutamoyl
residue, which was linked to the -amine group of
lysine26 through an amide bond (see Scheme 1). The
CON bond was observed to be cleaved in ECD (pro-
ducing a c=-type neutral fragment and a z·-fragment ion
in the same way as described above), which identified
the amino acid residue correctly as glutamoyl (seen in
Scheme 1 as the difference between 383 Da loss and the
255 Da loss). However, this cleavage was only observed
as the 2 peak in the region of the doubly-reduced
species [M  4H  2e]2 in low abundance. This could
be ascribed to the unfavorable formation of a primary
radical at C in the lysine26 side chain. In comparison,
Olsen et al. [22] studied electron capture dissociation of
peptide nucleic acids, where backbone cleavage was far
less abundant than for polypeptides. This was mainly
ascribed to the higher proton affinities of the nucleo-
bases. However, the different structure of the peptide
nucleic acid backbone compared to polypeptides was
perhaps another important aspect. The peptide nucleic
acid backbone consists ofN-(2-aminoethyl)glycine units
(not single -amino acid units), and upon hydrogen
attachment of the carbonyl and -cleavage, c= and
z·-ions would be produced analogs to polypeptide
backbone dissociation, but the z·-ions were now pri-
mary radical cations, not secondary, and thus less
abundant. Interestingly, in that study facile nucleobase
loss was observed from z·-ions, indicating further or
concomitant reactions of the less stable radical cations.
Further reactions of z·-ions are usually rare in conven-
tional ECD, but something that is a common feature in
hot electron capture dissociation [20, 23]. Furthermore,
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Scheme 1in a recent study by Cooper et al. [24] ECD of -peptidesgave no c=- or z·-fragment ions within the -amino acid
backbone chain, only a·- and y=-fragment ions were
observed. An isolated peptide bond unit seems to
fragment differently from -peptide bond chains.
Another abundant fragment ion that corresponded
to the full loss of the modification was observed from
both the triply and the doubly (less abundant) proton-
ated reduced charge states (marked in Figure 1 as X).
However, this fragment ion corresponded to a b, y=-type
cleavage producing the original nonmodified polypep-
tide. This could be explained by vibrational excitation of
[M  3H]3 species formed upon hydrogen desorption
from charge-reduced species, which was observed to
occur in ECD of small and medium-size polypeptides
[25]. Interestingly, the full modification was lost, not
only the palmitoyl moiety (having only one carbonyl
group). Therefore, at least two carbonyl groups sepa-
rated by three bonds (like b2-fragment ions) were nec-
essary for observing this loss. This emphasizes the need
for forming an oxazolone structure [26]. In fact, a very
weak signal was observed at m/z 368 corresponding to
the charged oxazolone structure of the glutamoyl-
palmitoyl moiety (Scheme 2). In the ECD mass spec-
trum of the derivatized polypeptide, no c=- nor z·-
sequence ions lost the -L-glutamyol(N-hexadecanoyl)
modification. Furthermore, Cooper et al. analyzed
branched peptides [24] having a N-triglycyl modifica-
tion on a lysine residue: AcA3K(G3)A3-NH2. This pep-
tide, in a similar manner, lost the full triglycyl modifi-
cation as observed in the present study. In the
mentioned study the loss of the full modification was
ascribed as a y=-ion fragment coming from the minor a·,
y=-fragmentation pathway in ECD, supported by the
observation of another y=-ion fragment. Cooper et al.
[24] also observed the cleavage of the modified lysine
side chain at the -carbon atom; this is not observed in
the present study. Interestingly, this loss was seen for a
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not possible.
For comparison, SORI-CAD was performed on the
quadruply charged 7GLP-137 derivative (mass spectrum
is shown in Figure 2). Here, 10 b-ions and 15 y=-
fragment ions were observed; cleaving 16 out of 30
possible inter-residue bonds (53%). A total of four
y=-ions lost the full modification and of those, only two
were observed without the modification making the
modification site ambiguous. No b-ions higher than b16
were observed. Nearly all major peaks were accompa-
nied by satellite peaks equivalent to water losses (and in
some cases, two consecutive water losses), from both b-
and y-ions, which complicated the spectrum severely.
This behavior was also observed in SORI-CAD of the
O-acylated polypeptide ghrelin [18]. The base peak in
the SORI-CAD spectrum was the quadruply charged
nonmodified polypeptide chain, corresponding to the
loss of the full modification. The branching site was
indeed a labile site, which helps explain why this loss
though much less prominent, was observed in ECD as
well. Although upon hydrogen desorption the [M  (n
 1)H](n1) species becomes vibrationally excited, the
energy dissipated in the even-electron cation would
only be enough for the lowest activation barrier to be
overcome, if any. Typically, rearrangement reaction
where bonds are both broken and formed would rep-
resent such low-energy activation barriers [27]. Further-
more, such reactions require, in general, a “tight”
transition complex to be formed (e.g., five-member
rings) that would lower the rate constant. On the
second-long timescales of the FTICR experiments, reac-
tions occurring with even very low rates would be
observed. The formation of oxazolone structures could
be considered such a reaction.
In the SORI-CAD spectrum (Figure 2) the modification
site and mass would have been correctly assigned as
N-acylated lysine residues [28, 29]. However, only in the
Figure 2. SORI-CAD MS/MS spectrum of the quadruply
charged -L-glutamyol(N-hexadecanoyl) modified Arg34-7GLP-
137 derivative. The inter residue cleavage sites are shown at the
upper right corner (dashed lines are shown for loss of modifica-
tion). Other symbols are the same as in Figure 1. Due to the off
resonance excitation at m/z 972 for 500 ms (10 V) a “blind spot”
occurs in this area, where no peaks are seen (20 scans).ECD spectrum would the two-part nature (glutamoyl-and palmitoyl-) of themodification have been successfully
revealed.
Conclusions
An N-acyl modified GLP-1 polypeptide derivative was
successfully analyzed and the modification site eluci-
dated. The modification that contained amide bonds,
produced common for ECD type cleavages, which
assisted in characterizing the modification structure
itself. This shows that ECD can not only elucidate the
primary sequence and reveal the modification sites, but
can also give information on the internal structure of
the modification by means of specific radical-site initi-
ated cleavages. Furthermore, the characterized poly-
peptide represented a branched polypeptide, the
branching point of which was successfully determined
as in a previous study [24].
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